Thoratec Corporation

NASDAQ:THOR ISIN:US8851753074

2012年5月24日

概览 | 新闻 | 多媒体 | 研究

Thoratec Corporation 公司资料

Thoratec Corporation (Thoratec) is a manufacturer of circulatory support products for use by patients with heart failure (HF). The Company develops, manufactures and markets products that are used by physicians and hospitals for cardiac assist, vascular and diagnostic applications. Thoratec operates in two business segments: Cardiovascular and International Technidyne Corporation (ITC), a wholly owned subsidiary. The Cardiovascular segment develops, manufactures and markets medical devices used for mechanical circulatory support (MCS). ITC designs, develops, manufactures and markets point-of-care diagnostic test systems and incision products. Cardiac assist and vascular graft products represented 61% of Thoratec's product sales during the fiscal year ended December 29, 2007, (fiscal 2007). Point-of-care blood diagnostics test systems and services and incision products amounted to 39% of the Company's total product sales in 2007.

公司详细信息

	主要部门	医疗器械

	支柱产业	医疗产品

	主页	www.thoratec.com

Key Developments: Thoratec Corporation

	2月16日澳洲股市：不能指望快速复苏 FEB 16, 2009 13:00 - 文章点击: 9,506 上周五澳洲股市收市扬升，澳股在美国政府制定计划帮助陷于困境的美国房屋业主的报告出台后的这一周以上涨结束。基本指数S&P/ASX200 上涨44.8点，或1.27%，报3,559.1点；综合指数上涨38.2点，或1.1%，报3,496.7点。奥巴马政府现在试图降低人们的期望，不要指望金融危机能快速解决，同时即将出台的盈利报告也可能会使市场下跌。